Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient
- 18 December 2006
- journal article
- case report
- Published by Elsevier in Journal of Hepatology
- Vol. 46 (3) , 531-538
- https://doi.org/10.1016/j.jhep.2006.11.016
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsGastroenterology, 2006
- Detection of rtN236T and rtA181V/T Mutations Associated with Resistance to Adefovir Dipivoxil in Samples from Patients with Chronic Hepatitis B Virus Infection by the INNO-LiPA HBV DR Line Probe Assay (Version 2)Journal of Clinical Microbiology, 2006
- Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensationJournal of Hepatology, 2005
- A new strategy for studyingin vitro the drug susceptibility of clinical isolates of human hepatitis B virusHepatology, 2004
- Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to LamivudineAntimicrobial Agents and Chemotherapy, 2004
- The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In VitroJournal of Virology, 2003
- Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase regionHepatology, 2001
- In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistanceHepatology, 2000
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998
- Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defectiveHepatology, 1998